Immune Complexes and the Risk of CVD in Type 1 Diabetes

We investigated whether the composition of modified forms of LDL in circulating immune complexes (LDL-ICs) was associated with cardiovascular disease (CVD) outcomes, including any CVD, major adverse cardiac and cerebrovascular events (MACCE), myocardial infarction (MI), and coronary artery disease,...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Diabetes
Autors principals: Lopes-Virella, Maria F., Bebu, Ionut, Hunt, Kelly J., Virella, Gabriel, Baker, Nathaniel L., Braffett, Barbara, Gao, Xiaoyu, Lachin, John M.
Format: Artigo
Idioma:Inglês
Publicat: American Diabetes Association 2019
Matèries:
Complications
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6702641/
https://ncbi.nlm.nih.gov/pubmed/31217176
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/db19-0358
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars